Review some of the top stories from the Contemporary Pediatrics website over the last week, and catch up on anything you may have missed.
Thank you for visiting the Contemporary Pediatrics® website. Take a look at some of our top stories from last week (Monday, October 9 to Friday, October 13, 2023) and click on each link to read and watch anything you may have missed.
1.) What's new in pediatric vaccines
A look at recent approvals and promising clinical trials for future vaccines, explained by Contemporary Pediatrics Editor in Chief, Tina Q. Tan, FAAP, FIDSA, FPIDS.
2.) FDA extends roflumilast cream 0.3% approval to treat plaque psoriasis in children 6 to 11 years
Once-daily, topical roflumilast cream 0.3% has been approved by the FDA for children aged 6 to 11 years for the treatment of plaque psoriasis based on a data from a 4-week Maximal Usage Systemic Exposure study, and safety and efficacy data from a pair of phase 3 trials in adults.
3.) Crinecerfont safe, effective in treating children with congenital adrenal hyperplasia
Crinecerfont, an investigational, oral, selective corticotropin-releasing factory type 1 receptor antagonist, achieved the primary and key secondary endpoints in a phase 3 study to treat congenital adrenal hyperplasia due to 21-hydroxylase deficiency in children aged 2 to 17 years.
4.) Overuse injuries in youth sports
In this Contemporary Pediatrics interview, Matthew A. Halanski, MD, discusses how overuse injuries can lead to complications if proper rest and treatment doesn't take place at the time of injury.
5.) Suspicious facial swelling in a 22-month-old girl
A 22-month-old female patient with sickle cell disease on folic acid and penicillin prophylaxis with a 3-day history of nasal congestion, rhinorrhea, fever and decreased oral intake presents to the emergency department (ED) for acute facial swelling noted when she woke up from a nap. What's the diagnosis?